Acorda Therapeutics to Conduct 1-for-20 Reverse Stock Split
PEARL RIVER, N.Y.–(BUSINESS WIRE)–Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will conduct a…
Month: May 2023
Biosenta Inc. ceases negotiations with Voran Group Ventures Ltd.
CALGARY, Alberta, May 31, 2023 (GLOBE NEWSWIRE) — Biosenta Inc. ( “Biosenta”) (CSE: ZRO) announces…
Lattice Wins 2023 Fortress Cyber Security Award
HILLSBORO, Ore.–(BUSINESS WIRE)–$LSCC #FPGA—Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that…
Expert Healthcare Banker Craig Evans Joins BankUnited Corporate Banking
Takes the role of senior vice president, enterprise practice leader, specialized lending MIAMI LAKES, Fla.–(BUSINESS…
Global Survey Suggests Consumers Overestimate their Ability to Detect Deepfakes
New global research from Jumio reveals disconnect between consumer awareness of generative AI and deepfakes…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Comerica Incorporated (CMA) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Santhera Publishes Annual Report 2022
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, May 31, 2023 – Santhera Pharmaceuticals…
Santhera Publishes Annual Report 2022
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, May 31, 2023 – Santhera Pharmaceuticals…
eFFECTOR Therapeutics Announces Closing of $7.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 31, 2023 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics,…
eFFECTOR Therapeutics Announces Closing of $7.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 31, 2023 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics,…
BioSyent Announces Approval of New Product
MISSISSAUGA, Ontario, May 31, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
BioSyent Announces Approval of New Product
MISSISSAUGA, Ontario, May 31, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
Telesis Bio Secures Financing of $28.0 Million
Up to an Additional $46.2 Million Available Through Warrant Exercise Led by Novalis LifeSciences LLC…
Telesis Bio Secures Financing of $28.0 Million
Up to an Additional $46.2 Million Available Through Warrant Exercise Led by Novalis LifeSciences LLC…
Oncternal Therapeutics to Participate at the 2023 Jefferies Healthcare Conference
SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Oncternal Therapeutics to Participate at the 2023 Jefferies Healthcare Conference
SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Enliven Therapeutics to Present at Two Upcoming Investor Conferences
BOULDER, Colo., May 31, 2023 (GLOBE NEWSWIRE) — Enliven Therapeutics, Inc. (Enliven) (Nasdaq: ELVN), a…
Enliven Therapeutics to Present at Two Upcoming Investor Conferences
BOULDER, Colo., May 31, 2023 (GLOBE NEWSWIRE) — Enliven Therapeutics, Inc. (Enliven) (Nasdaq: ELVN), a…
Cronos Group Announces Streamlined Operating Structure to Improve Cash Flow
Plans to Exit Existing U.S. hemp-derived CBD Operations Intends to Launch Lord Jones® Brand in…
Cronos Group Announces Streamlined Operating Structure to Improve Cash Flow
Plans to Exit Existing U.S. hemp-derived CBD Operations Intends to Launch Lord Jones® Brand in…